Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction.
Latifoltojar A, Hall-Craggs M, Bainbridge A, Rabin N, Popat R, Rismani A, D'Sa S, Dikaios N, Sokolska M, Antonelli M, Ourselin S, Yong K, Taylor SA, Halligan S, Punwani S. Latifoltojar A, et al. Eur Radiol. 2017 Dec;27(12):5325-5336. doi: 10.1007/s00330-017-4907-8. Epub 2017 Jun 27. Eur Radiol. 2017. PMID: 28656463 Free PMC article.
Diagnostic utility of whole body Dixon MRI in multiple myeloma: A multi-reader study.
Bray TJP, Singh S, Latifoltojar A, Rajesparan K, Rahman F, Narayanan P, Naaseri S, Lopes A, Bainbridge A, Punwani S, Hall-Craggs MA. Bray TJP, et al. Among authors: latifoltojar a. PLoS One. 2017 Jul 3;12(7):e0180562. doi: 10.1371/journal.pone.0180562. eCollection 2017. PLoS One. 2017. PMID: 28672007 Free PMC article.
Whole-body MRI for staging and interim response monitoring in paediatric and adolescent Hodgkin's lymphoma: a comparison with multi-modality reference standard including 18F-FDG-PET-CT.
Latifoltojar A, Punwani S, Lopes A, Humphries PD, Klusmann M, Menezes LJ, Daw S, Shankar A, Neriman D, Fitzke H, Clifton-Hadley L, Smith P, Taylor SA. Latifoltojar A, et al. Eur Radiol. 2019 Jan;29(1):202-212. doi: 10.1007/s00330-018-5445-8. Epub 2018 Jun 15. Eur Radiol. 2019. PMID: 29948084 Free PMC article. Clinical Trial.
Multiparametric whole-body 3.0-T MRI in newly diagnosed intermediate- and high-risk prostate cancer: diagnostic accuracy and interobserver agreement for nodal and metastatic staging.
Johnston EW, Latifoltojar A, Sidhu HS, Ramachandran N, Sokolska M, Bainbridge A, Moore C, Ahmed HU, Punwani S. Johnston EW, et al. Among authors: latifoltojar a. Eur Radiol. 2019 Jun;29(6):3159-3169. doi: 10.1007/s00330-018-5813-4. Epub 2018 Dec 5. Eur Radiol. 2019. PMID: 30519933 Free PMC article.
Hyperpolarised 13C MRI: a new horizon for non-invasive diagnosis of aggressive breast cancer.
Abeyakoon O, Latifoltojar A, Gong F, Papoutsaki MV, Chowdhury R, Glaser M, Jeraj H, Awais R, Holt C, Twyman F, Arstad E, Gadian DG, Atkinson D, Comment A, O'Callaghan J, Smith L, Beeston T, Clemente J, Patani N, Stein R, Yuneva M, Szabadkai G, Halligan S, Punwani S. Abeyakoon O, et al. Among authors: latifoltojar a. BJR Case Rep. 2019 May 15;5(3):20190026. doi: 10.1259/bjrcr.20190026. eCollection 2019 Sep. BJR Case Rep. 2019. PMID: 31555479 Free PMC article.
26 results